These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7695815)

  • 21. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
    Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
    J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
    Anichini E; Fibbi G; Pucci M; Caldini R; Chevanne M; Del Rosso M
    Exp Cell Res; 1994 Aug; 213(2):438-48. PubMed ID: 8050501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on functional and structural role of urokinase receptor and other components of the plasminogen activation system in malignancy.
    Weidle UH; Wöllisch E; Rønne E; Ploug M; Behrendt N; de Vries TJ; Quax PH; Verheijen JH; van Muijen GN; Ruiter DJ
    Ann Biol Clin (Paris); 1994; 52(11):775-82. PubMed ID: 7747886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
    Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
    Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein structure and membrane anchorage of the cellular receptor for urokinase-type plasminogen activator.
    Ploug M; Behrendt N; Løber D; Danø K
    Semin Thromb Hemost; 1991 Jul; 17(3):183-93. PubMed ID: 1665583
    [No Abstract]   [Full Text] [Related]  

  • 27. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization.
    Kindzelskii AL; Laska ZO; Todd RF; Petty HR
    J Immunol; 1996 Jan; 156(1):297-309. PubMed ID: 8598477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
    Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
    Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense targeting of the urokinase receptor blocks urokinase-dependent proliferation, chemoinvasion, and chemotaxis of human synovial cells and chondrocytes in vitro.
    Fibbi G; Pucci M; Serni U; Cerinic MM; Del Rosso M
    Proc Assoc Am Physicians; 1998; 110(4):340-50. PubMed ID: 9686682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
    Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS
    Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting urokinase-type plasminogen activator and its receptor for cancer therapy.
    Nozaki S; Endo Y; Nakahara H; Yoshizawa K; Ohara T; Yamamoto E
    Anticancer Drugs; 2006 Nov; 17(10):1109-17. PubMed ID: 17075310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A urokinase receptor mRNA binding protein-mRNA interaction regulates receptor expression and function in human pleural mesothelioma cells.
    Shetty S; Idell S
    Arch Biochem Biophys; 1998 Aug; 356(2):265-79. PubMed ID: 9705217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q; Liu Y; Liu K; Byrne S; Liu G; Wang X; Li Z; Ockleford CD
    Placenta; 2000; 21(2-3):184-93. PubMed ID: 10736241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The structure and function of urokinase receptor and its expression in neoplastic tissues].
    Tang H; Zhu Y; Song H
    Zhonghua Yi Xue Za Zhi; 1995 May; 75(5):315-7. PubMed ID: 7656166
    [No Abstract]   [Full Text] [Related]  

  • 35. The urokinase-type plasminogen activator receptor is a member of the Ly-6 superfamily.
    Palfree RG
    Immunol Today; 1991 May; 12(5):170. PubMed ID: 1652256
    [No Abstract]   [Full Text] [Related]  

  • 36. The growth factor module of urokinase is the binding sequence for its receptor.
    Appella E; Blasi F
    Ann N Y Acad Sci; 1987; 511():192-5. PubMed ID: 2830824
    [No Abstract]   [Full Text] [Related]  

  • 37. Cryptic urokinase binding sites on human foreskin fibroblasts.
    Bajpai A; Baker JB
    Biochem Biophys Res Commun; 1985 Dec; 133(2):475-82. PubMed ID: 3002345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisense oligonucleotides against the urokinase receptor: a therapeutic strategy for the control of cell invasion in rheumatoid arthritis and cancer.
    Del Rosso M; Fibbi G; Pucci M; Cerinic MM
    Clin Exp Rheumatol; 1998; 16(4):389-93. PubMed ID: 9706415
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Duffy MJ; Duggan C
    J Natl Cancer Inst; 1997 Nov; 89(21):1628-30. PubMed ID: 9362165
    [No Abstract]   [Full Text] [Related]  

  • 40. A novel urokinase receptor on monocyte-like macrophage cell line.
    Bayraktutan U; Jones P
    Biochem Soc Trans; 1993 Nov; 21(4):395S. PubMed ID: 8131971
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.